Schedule 13D ownership disclosure
Evofem Biosciences Operations, Inc.
Security class unavailable · CUSIP: 30048L104
Event date: 2018-01-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,037,498
- Percent of class
- 39.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000914208-18-000012
- Form type
- SC 13D
- Filer
- Evofem Biosciences Operations, Inc.
- CIK
- CIK 1659886
- Filed
- Jan 18, 2018
- Reporting period
- Jan 17, 2018
- Description
- Schedule 13D beneficial ownership